Cardiac Toxicity Completed Phase 3 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0028520 (Cardiac Toxicity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002827Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's DiseaseTreatment
NCT00005578Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's DiseaseTreatment